Unilever is set to acquire US-based nutritional supplements brand Grüns for an undisclosed sum, marking its first acquisition since agreeing to merge its food business with McCormick & Company in a deal that would create a $65 billion food giant.
Founded in 2023, Grüns has quickly gained traction in the wellness space with its gummy-based supplements made from fruits and vegetables. The company was valued at $500 million during its Series B funding round in 2025.
The acquisition is expected to strengthen Unilever’s growing presence in the wellbeing and nutrition segment, particularly in the U.S. market. The consumer goods major has been steadily building a portfolio of supplement brands over the past few years, including Nutrafol, acquired in 2022, SmartyPants Vitamins in 2020, and Olly Nutrition in 2019.
The move also mirrors a similar strategy in India by Hindustan Unilever. During its third-quarter earnings in February 2026, the company announced the full acquisition of nutraceutical brand OZiva, investing Rs 824 crore to acquire the remaining 49% stake in Zywie Ventures Private Limited.
Hindustan Unilever had previously acquired a 51% stake in Zywie Ventures in 2022. Following the latest transaction, approved under a pre-agreed valuation framework, OZiva is set to become a wholly owned subsidiary of the company.
Unilever’s latest deal underscores its continued pivot towards high-growth health and wellness categories, as it looks to diversify beyond traditional consumer goods and tap into rising global demand for nutritional supplements.
First Published on April 10, 2026, 21:31:20 IST
